In our investigation of the molecular mechanism by which ZMIZ2 promotes the malignant phenotype of lung cancer cells, we found that ZMIZ2 significantly enhanced the expression of the key target genes associated with the Wnt pathway. The gene discussed is ZMIZ2; the disease is lung carcinoma.